Lipid balance and chemoresistance in cancer cells
eLife · 2026
DOI: 10.7554/elife.110231 ↗Kurz gefasst
Editorial in der Zeitschrift eLife, 2026. Verfasst von Kaori Kanemaru und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Biological Science, Faculty of Science and Technology, and the Division of Aging Biology, Research Institute for Science and Te…. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Sphingomyelins, Antineoplastic Agents, Cholesterol. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A shift in the balance between two lipids – cholesterol and sphingomyelin – makes hybrid epithelial-mesenchymal cancer cells less responsive to certain chemotherapy drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Applied Biological Science, Faculty of Science and Technology, and the Division of Aging Biology, Research Institute for Science and Technology, Tokyo University of Science, Tokyo, Japan.
ORCID-Profile: Kaori Kanemaru, Yoshikazu Nakamura
Zitieren
APA
Kanemaru, K., & Nakamura, Y. (2026). Lipid balance and chemoresistance in cancer cells. eLife. https://doi.org/10.7554/elife.110231
Vancouver
Kanemaru K, Nakamura Y. Lipid balance and chemoresistance in cancer cells. eLife. 2026. doi:10.7554/elife.110231
BibTeX
@article{Kanemaru2026,
author = {Kanemaru, Kaori and Nakamura, Yoshikazu},
title = {Lipid balance and chemoresistance in cancer cells},
journal = {eLife},
year = {2026},
doi = {10.7554/elife.110231}
}
EUVIMED